Skip to content

Clinical trials

Arthritis, Rheumatoid trials in the United States with no applicable phase

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Arthritis, Rheumatoid Phase: Not applicable Country / region: United States Clear all

162 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20015
20022
20037
20045
20054
20062
20073
20083
200912
20103
20113
20128
20135
201410
20153
20168
20174
20189
20193
202010
20219
202213
20237
20243
202511
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed108
Active, not recruiting13
Recruiting13
Terminated13
Unknown status8
Withdrawn3
Enrolling by invitation3
Not yet recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Zimmer Biomet13
DePuy Orthopaedics10
Brigham and Women's Hospital9
Duke University7
Johns Hopkins University5
Physicians Committee for Responsible Medicine4
University of California, Los Angeles4
University of California, San Francisco4
NYU Langone Health3
University of Michigan3

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Arthritis, Rheumatoid162
Osteoarthritis49
Arthritis30
Osteonecrosis17
Pain9
Arthritis, Psoriatic8
Fibromyalgia8
Lupus Erythematosus, Systemic8
Osteoarthritis, Knee8
Osteoarthritis, Hip6

Trials

Showing 1 to 25 of 162. Each trial links to its page on Pharma Observatory.

62 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.